- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 90,420 | 02.07.24 17:35:47 | -1,590 | -1,73% | 0,000 | 0,000 | 91,260 | 92,010 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.044,660 | 02.07.24 22:00:06 | -12,360 | -1,17% | 1.044,140 | 1.045,020 | 1.047,110 | 1.057,020 |
